Teacher:In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Teacher: Now, understand the problem? Solve this instance: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Consumer Products Safe Testing
Act''.

SEC. 2. FINDINGS AND POLICY.

(a) Findings.--The Congress finds that--
(1) nonanimal acute toxicity tests have been developed in
recent years that have shown a level of reliability sufficient
for the reduction or replacement of animal acute toxicity tests
such as the Draize test for many products regulated by the
Federal Government;
(2) many manufacturers have found nonanimal acute toxicity
tests to be adequate for evaluating the safety of products for
the purposes of complying with Federal regulations or
guidelines;
(3) the Federal Government has discouraged the use of these
alternatives through regulations that mandate or encourage the
use of animal acute toxicity tests, or by not prescribing
other, less costly, more accurate and humane alternatives;
(4) many manufacturers are reluctant to use nonanimal tests
without encouragement from the Federal Government; and
(5) private industry and the consumer will benefit from the
promotion of alternative methods of testing when these
alternatives are as accurate and more humane than animal tests.
(b) Policy.--Federal departments and agencies shall encourage the
development and use of product testing procedures that accurately
reflect the acute health effects on humans of certain products,
including consumer products and products containing hazardous or toxic
substances, but which do not rely upon animals.

SEC. 3. FEDERAL ACTION.

(a) Review of Regulations, Guidelines, or Recommendations
Concerning the Draize Test and Other Animal Acute Toxicity Tests.--Not
later than one year after the date of enactment of this Act, each
Federal department or agency head shall--
(1) review and evaluate any regulation, guideline, or
recommendation issued by that department or agency which
requires, recommends, or encourages the use of the Draize or
other animal acute toxicity test for the purpose of evaluation
of the safety of a regulated product;
(2) review and evaluate nonanimal alternatives with the
potential for partial or full replacement of the Draize or
other animal acute toxicity test for some or all of the
products regulated; and
(3) promulgate regulations, guidelines, or recommendations
that specify a nonanimal acute toxicity test or battery of
tests should be used instead of an animal acute toxicity test
unless that Federal department or agency head determines that
the nonanimal acute toxicity test or battery of such tests is
less likely to predict the acute health effects on humans of a
product than the animal acute toxicity test.
(b) Animal Acute Toxicity Tests.--If a determination is made that
no nonanimal acute toxicity test or battery of tests is as likely to
predict the human reaction to the regulated product as the Draize or
other animal acute toxicity test, the appropriate Federal department or
agency head shall publish in the Federal Register an explanation of all
options considered and the justification for continuing the animal
acute toxicity test, which shall be subject to public comment.
(c) Periodic Review of Animal Acute Toxicity Testing Regulations.--
At least every 2 years (beginning 3 years after the date of enactment
of this Act), each Federal department or agency head, after considering
the most recent technological advances available, shall determine
whether continued use of any animal acute toxicity test is justified.
If a Federal department or agency head determines that such use is
justified, then that Federal department or agency head shall publish an
explanation and justification of such continued use in the Federal
Register, which shall be subject to public comment.

SEC. 4. APPLICATION.

This Act shall not apply to regulations, guidelines, or
recommendations related to medical research.

SEC. 5. DEFINITIONS.

For purposes of this Act:
(1) Animal.--The term ''animal'' means any vertebrate.
(2) Animal acute toxicity test.--The term ''animal acute
toxicity test'' means an acute toxicity test on animals,
including (but not limited to) the Draize eye or skin irritancy
test, LD-50 test, approximate lethal dose test, and the limit
test.
(3) Federal department or agency head.--The term ''Federal
department or agency head'' means the head of a Federal
department or agency who--
(A) has authority to promulgate regulations,
guidelines, and recommendations with respect to
procedures to be used in the safety testing by
manufacturers of products, including consumer products,
veterinary products, and products containing hazardous
or toxic substances; or
(B) licenses or approves products, labeling
requirements or the transportation of products based on
the results of these tests.
(4) Medical research.--The term ''medical research'' means
research related to the causes, diagnosis, treatment, or
control of physical or mental impairments of humans or animals.
The term does not include the testing of a product to determine
its toxicity for the purpose of complying with protocols,
recommendations, or guidelines for testing required,
recommended, or accepted by a Federal regulatory agency for a
product introduced in commerce.
(5) Nonanimal acute toxicity test.--The term ''nonanimal
acute toxicity test'' means an acute toxicity test not
conducted on animals. Such tests include (but are not limited
to) cell culture, computer modeling, protein alteration, and
chorioallantoic membrane techniques.
Student:
Consumer Products Safe Testing Act - Requires each Federal department or agency (department) head to: (1) evaluate any regulation, guideline, or recommendation issued by that department which requires, recommends, or encourages the use of the Draize or other animal acute toxicity test (animal test) to evaluate the safety of a regulated product; (2) evaluate nonanimal alternatives with the potential for partial or full replacement of such test; and (3) promulgate regulations, guidelines, or recommendations that specify a nonanimal acute toxicity test or battery of tests that should be used instead of an animal test unless the nonanimal test is less likely to predict the acute health effects of a product on humans.
Directs the appropriate Federal department, if a determination is made that no nonanimal test is as likely to predict the human reaction to the regulated product as the animal test, to publish in the Federal Register an explanation of all options considered and the justification for continuing the animal test, which shall be subject to public comment.
Requires each Federal department head, at least every two years (beginning three years after this Act's enactment date), after considering the most recent technological advances available, to determine whether continued use of any animal test is justified (and if the department head determines that such use is justified, such head shall publish an explanation and justification for such continued use in the Federal Register, which shall be subject to public comment).
Makes this Act inapplicable to regulations, guidelines, or recommendations related to medical research.